Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Establishing a cryopreservation protocol for patient-derived xenografts of prostate cancer.

Porter LH, Lawrence MG, Wang H, Clark AK, Bakshi A, Obinata D, Goode D, Papargiris M, Mural, Clouston D, Ryan A, Norden S, Corey E, Nelson PS, Isaacs JT, Grummet J, Kourambas J, Sandhu S, Murphy DG, Pook D, Frydenberg M, Taylor RA, Risbridger GP.

Prostate. 2019 Aug;79(11):1326-1337. doi: 10.1002/pros.23839. Epub 2019 Jun 18.

PMID:
31212368
2.

Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer.

Watt MJ, Clark AK, Selth LA, Haynes VR, Lister N, Rebello R, Porter LH, Niranjan B, Whitby ST, Lo J, Huang C, Schittenhelm RB, Anderson KE, Furic L, Wijayaratne PR, Matzaris M, Montgomery MK, Papargiris M, Norden S, Febbraio M, Risbridger GP, Frydenberg M, Nomura DK, Taylor RA.

Sci Transl Med. 2019 Feb 6;11(478). pii: eaau5758. doi: 10.1126/scitranslmed.aau5758.

PMID:
30728288
3.

Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy.

Lawrence MG, Obinata D, Sandhu S, Selth LA, Wong SQ, Porter LH, Lister N, Pook D, Pezaro CJ, Goode DL, Rebello RJ, Clark AK, Papargiris M, Van Gramberg J, Hanson AR, Banks P, Wang H, Niranjan B, Keerthikumar S, Hedwards S, Huglo A, Yang R, Henzler C, Li Y, Lopez-Campos F, Castro E, Toivanen R, Azad A, Bolton D, Goad J, Grummet J, Harewood L, Kourambas J, Lawrentschuk N, Moon D, Murphy DG, Sengupta S, Snow R, Thorne H, Mitchell C, Pedersen J, Clouston D, Norden S, Ryan A, Dehm SM, Tilley WD, Pearson RB, Hannan RD, Frydenberg M, Furic L, Taylor RA, Risbridger GP.

Eur Urol. 2018 Nov;74(5):562-572. doi: 10.1016/j.eururo.2018.06.020. Epub 2018 Jul 23.

PMID:
30049486
4.

Enduring epigenetic landmarks define the cancer microenvironment.

Pidsley R, Lawrence MG, Zotenko E, Niranjan B, Statham A, Song J, Chabanon RM, Qu W, Wang H, Richards M, Nair SS, Armstrong NJ, Nim HT, Papargiris M, Balanathan P, French H, Peters T, Norden S, Ryan A, Pedersen J, Kench J, Daly RJ, Horvath LG, Stricker P, Frydenberg M, Taylor RA, Stirzaker C, Risbridger GP, Clark SJ.

Genome Res. 2018 May;28(5):625-638. doi: 10.1101/gr.229070.117. Epub 2018 Apr 12.

5.

Environmental DNA (eDNA) detects the pool frog (Pelophylax lessonae) at times when traditional monitoring methods are insensitive.

Eiler A, Löfgren A, Hjerne O, Nordén S, Saetre P.

Sci Rep. 2018 Apr 3;8(1):5452. doi: 10.1038/s41598-018-23740-5.

6.

Interventions in hospitalised patients with cancer: the importance of impending death awareness.

Geijteman ECT, Graaf MV, Witkamp FE, Norden SV, Stricker BH, van der Rijt CCD, van der Heide A, van Zuylen L.

BMJ Support Palliat Care. 2018 Sep;8(3):278-281. doi: 10.1136/bmjspcare-2017-001466. Epub 2018 Feb 9.

PMID:
29440148
7.

New Histopathological & Genetic Features to Improve Active Surveillance Selection for Low-Risk Prostate Cancer.

Chu K, Corcoran N, Norden S, Wong LM.

Anticancer Agents Med Chem. 2018;18(7):951-957. doi: 10.2174/1871520617666171114105846.

PMID:
29141559
8.

Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cells.

Porter LH, Hashimoto K, Lawrence MG, Pezaro C, Clouston D, Wang H, Papargiris M, Thorne H, Li J; kConFab, Ryan A, Norden S, Moon D, Bolton DM, Sengupta S, Frydenberg M, Murphy DG, Risbridger GP, Taylor RA.

BJU Int. 2018 Jun;121(6):971-978. doi: 10.1111/bju.14043. Epub 2017 Oct 26.

9.

Routinely reported 'equivocal' lymphovascular invasion in prostatectomy specimens is associated with adverse outcomes.

Galiabovitch E, Hovens CM, Peters JS, Costello AJ, Battye S, Norden S, Ryan A, Corcoran NM.

BJU Int. 2017 Apr;119(4):567-572. doi: 10.1111/bju.13594. Epub 2016 Aug 31.

10.

A Distributed Network for Social Cognition Enriched for Oxytocin Receptors.

Mitre M, Marlin BJ, Schiavo JK, Morina E, Norden SE, Hackett TA, Aoki CJ, Chao MV, Froemke RC.

J Neurosci. 2016 Feb 24;36(8):2517-35. doi: 10.1523/JNEUROSCI.2409-15.2016.

11.

The impact of low and intermediate-level radioactive waste on humans and the environment over the next one hundred thousand years.

Kautsky U, Saetre P, Berglund S, Jaeschke B, Nordén S, Brandefelt J, Keesmann S, Näslund JO, Andersson E.

J Environ Radioact. 2016 Jan;151 Pt 2:395-403. doi: 10.1016/j.jenvrad.2015.06.025. Epub 2015 Jul 14.

12.

Establishment of primary patient-derived xenografts of palliative TURP specimens to study castrate-resistant prostate cancer.

Lawrence MG, Pook DW, Wang H, Porter LH, Frydenberg M, Kourambas J, Appu S, Poole C, Beardsley EK, Ryan A, Norden S, Papargiris MM, Risbridger GP, Taylor RA.

Prostate. 2015 Sep;75(13):1475-83. doi: 10.1002/pros.23039. Epub 2015 Jul 14.

PMID:
26177841
13.

Inferences about radionuclide mobility in soils based on the solid/liquid partition coefficients and soil properties.

Sohlenius G, Saetre P, Nordén S, Grolander S, Sheppard S.

Ambio. 2013 May;42(4):414-24. doi: 10.1007/s13280-013-0408-4.

14.

A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer.

Clark AK, Taubenberger AV, Taylor RA, Niranjan B, Chea ZY, Zotenko E, Sieh S, Pedersen JS, Norden S, Frydenberg M, Grummet JP, Pook DW; Australian Prostate Cancer BioResource, Stirzaker C, Clark SJ, Lawrence MG, Ellem SJ, Hutmacher DW, Risbridger GP.

Biomaterials. 2013 Jul;34(20):4777-85. doi: 10.1016/j.biomaterials.2013.03.005. Epub 2013 Apr 2.

PMID:
23562048
15.

A preclinical xenograft model of prostate cancer using human tumors.

Lawrence MG, Taylor RA, Toivanen R, Pedersen J, Norden S, Pook DW, Frydenberg M; Australian Prostate Cancer BioResource, Papargiris MM, Niranjan B, Richards MG, Wang H, Collins AT, Maitland NJ, Risbridger GP.

Nat Protoc. 2013 May;8(5):836-48. doi: 10.1038/nprot.2013.043. Epub 2013 Apr 4.

PMID:
23558784
16.

Analysis of malpractice claims with a focus on oxytocin use in labour.

Jonsson M, Nordén SL, Hanson U.

Acta Obstet Gynecol Scand. 2007;86(3):315-9.

PMID:
17364306
17.

Hormone receptor expression in male breast cancers.

Akosa A, Van Norden S, Tettey Y.

Ghana Med J. 2005 Mar;39(1):14-8.

18.

Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease.

Wright NA, Poulsom R, Stamp G, Van Norden S, Sarraf C, Elia G, Ahnen D, Jeffery R, Longcroft J, Pike C, et al.

Scand J Gastroenterol Suppl. 1992;193:76-82.

PMID:
1290063
19.

An inexpensive caging method for miniature swine suitable for trace-element studies.

Hunsaker HA, Norden SE, Allen KG.

Lab Anim Sci. 1984 Aug;34(4):386-7.

PMID:
6482379
20.

A comfortable, minimum stress method of restraint for Yucatan miniature swine.

Panepinto LM, Phillips RW, Norden S, Pryor PC, Cox R.

Lab Anim Sci. 1983 Feb;33(1):95-7.

PMID:
6834782

Supplemental Content

Loading ...
Support Center